髋部病理性或即将发生病理性骨折关节置换术后的风险与并发症
本研究利用大型前瞻性登记数据库,纳入2011至2018年间接受半髋或全髋关节置换术的患者,按手术指征分为病理性骨折、非病理性骨折和骨关节炎三组。其发病率与死亡率与非病理性骨折组相似,但围手术期输血率和非计划再入院率更高。
要点
- 病理性骨折组非计划重返手术室率为4.98%,肺部并发症率为3.85%。
- 病理性骨折组围手术期输血率和非计划再入院率高于非病理性骨折组。
核心结论
- 髋关节置换术治疗股骨近端病理性骨折患者的发病率与死亡率高于骨关节炎队列。
- 病理性骨折患者与非病理性骨折患者的发病率与死亡率相似,但围手术期输血率和非计划再入院率更高。
研究设计与样本
- 利用大型前瞻性收集的登记数据库,识别2011至2018年间接受半髋或全髋关节置换术的患者。
- 按手术指征分为病理性骨折、非病理性骨折和骨关节炎三组,比较基线特征和术后并发症。
主要发现
- 共识别883例因病理性骨折接受半髋或全髋关节置换术的患者。
- 病理性骨折患者相对骨关节炎队列年龄更大、体重指数更低、术前合并症显著更多。
- 病理性骨折患者手术时间较骨关节炎和非病理性骨折队列分别延长27分钟和25分钟。
临床怎么用
- 对股骨近端病理性骨折行髋关节置换术的患者,应关注围手术期输血需求和非计划再入院风险。
局限性
- 证据等级为III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment options for metastatic osseous lesions of the proximal femur include hemiarthroplasty (HA) or total hip arthroplasty (THA) depending on lesion characteristics and patient demographics. Studies assessing short-term outcomes after HA/THA in this patient population are limited. Therefore, the purpose of this present study was to identify short-term rates of morbidity and mortality after HA/THA for pathological proximal femur fractures, as well as readmission and reoperation rates and reasons. METHODS: This study utilized a large, prospectively collected registry to identify patients who underwent HA/THA between 2011 and 2018. Patients were stratified by indication for surgery, including pathological fracture, nonpathological fracture, and osteoarthritis. Baseline patient characteristics and postoperative complications were compared using bivariate and/or multivariate analysis. RESULTS: In total, 883 patients undergoing HA/THA for a pathological fracture were identified. Relative to an osteoarthritis cohort, these patients tended to be older, had a lower body mass index, and had significantly more preoperative comorbidities. These patients had high rates of total complications (13.93%), including thirty-day mortality (3.29%), unplanned return to the operating room (4.98%), and pulmonary complications (3.85%). Patients with pathological fracture had a longer operative duration relative to osteoarthritis and nonpathological cohorts (+27 and +25 minutes, respectively), despite having high rates of HAs performed. CONCLUSION: Patients undergoing hip arthroplasty for pathologic proximal femur fracture have increased morbidity and mortality relative to an osteoarthritis cohort. However, patients with a pathological fracture have similar rates of morbidity and mortality when compared with a nonpathological fracture cohort, but did experience higher rates of perioperative blood transfusion and unplanned readmissions. LEVEL OF EVIDENCE: III.
引用
- Boddapati V, Held MB, Levitsky M, et al. Risks and Complications After Arthroplasty for Pathological or Impending Pathological Fracture of the Hip. J Arthroplasty. 2021. PMID: 33640182. doi:10.1016/j.arth.2021.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。